Are sarcoma centers needed in Germany?: Experience gained with the Bonner GIST register;Brauchen wir in Deutschland Sarkomzentren?: Erfahrungen aus dem Bonner GIST-Register

Pathologe

Volumn 32, Issue 1, 2011, Pages 72-75

  Wardelmann, E ^a   Merkelbach Bruse, S ^a   Schildhaus, H U ^a   Buttner R ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Gastrointestinal stromal tumors; Mutations; Register; Sarcomas

Indexed keywords

ADULT; ARTICLE; COOPERATION; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL STROMAL TUMOR; GENETIC MARKER; GENETICS; GERMANY; HEALTH SERVICE; HOSPITAL; HUMAN; INTERDISCIPLINARY COMMUNICATION; NUCLEOTIDE SEQUENCE; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATIENT CARE; PROGNOSIS; REGISTER; SARCOMA; SOFT TISSUE TUMOR; STATISTICS; TREATMENT OUTCOME;

ADULT; COOPERATIVE BEHAVIOR; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GASTROINTESTINAL STROMAL TUMORS; GENETIC MARKERS; GERMANY; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALS, SPECIAL; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE TEAM; PROGNOSIS; REGISTRIES; SARCOMA; SOFT TISSUE NEOPLASMS; TREATMENT OUTCOME;

EID: 79952450240     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1398-7     Document Type: Article

References (12)

1. Blanke C, Rankin C, Demetri G et al (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626-632 (Pubitemid 351264358)
2. Kindblom LG, Remotti HE, Aldenborg F et al (1998) Gastrointestinal pacemaker cell tumor (GIPACT) - Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152:1259-1269 (Pubitemid 28221878)
3. Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580 (Pubitemid 28067289)
4. Wardelmann E, Losen I, Hans V et al (2003) Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors. Int J Cancer 106:887-895 (Pubitemid 37071667)
5. Wardelmann E, Neidt I, Bierhoff E et al (2002) c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol 15:125-136 (Pubitemid 34171322)
6. Wardelmann E, Hrychyk A, Merkelbach-Bruse S et al (2004) Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn 6:197-204 (Pubitemid 39136646)
7. Schildhaus H, Cavlar T, Binot E et al (2008) Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol 216:176-182
8. Demetri G, Mehren M von, Antonescu C et al (2010) NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw 8:S1-S41
9. Casali P, Blay J, Experts ECECPo (2010) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v98-v102
10. Merkelbach-Bruse S, Dietmaier W, Füzesi L et al (2010) Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. BMC Med Genet 11:106
11. Engström K, Bergh P, Gustafson P et al (2008) Liposarcoma: outcome based on the Scandinavian Sarcoma Group register. Cancer 113:1649-1656
12. Nilsson B, Bümming P, Meis-Kindblom JM et al (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course and prognostication in the preimatinib mesylate era - a population- based study in western Sweden. Cancer 103:821-829 (Pubitemid 40216412)